Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Prostate Cancer

  Free Subscription


25.05.2020

1 BJU Int
3 BMC Cancer
1 Br J Cancer
1 Cancer Res
1 Eur Radiol
1 Int J Urol
1 J Natl Cancer Inst
1 PLoS One
1 Proc Natl Acad Sci U S A
3 Prostate
1 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BJU Int

  1. WURNSCHIMMEL C, Maurer T, Knipper S, von Breunig F, et al
    Martini-Klinik experience on prostate cancer surgery during the early phase of COVID-19.
    BJU Int. 2020 May 18. doi: 10.1111/bju.15115.
    PubMed         Abstract available


    BMC Cancer

  2. MOORE C, Palau VE, Mahboob R, Lightner J, et al
    Upregulation of pERK and c-JUN by gamma-tocotrienol and not alpha-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells.
    BMC Cancer. 2020;20:428.
    PubMed         Abstract available

  3. DUDKA I, Thysell E, Lundquist K, Antti H, et al
    Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status.
    BMC Cancer. 2020;20:437.
    PubMed         Abstract available

  4. VUOLUKKA K, Auvinen P, Palmgren JE, Aaltomaa S, et al
    Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.
    BMC Cancer. 2020;20:453.
    PubMed         Abstract available


    Br J Cancer

  5. BUTLER EN, Kelly SP, Coupland VH, Rosenberg PS, et al
    Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment.
    Br J Cancer. 2020 May 20. pii: 10.1038/s41416-020-0859.
    PubMed         Abstract available


    Cancer Res

  6. LI S, Fong KW, Gritsina G, Zhang A, et al
    Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer.
    Cancer Res. 2020;80:2072.
    PubMed        


    Eur Radiol

  7. DE ROOIJ M, Israel B, Tummers M, Ahmed HU, et al
    ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.
    Eur Radiol. 2020 May 19. pii: 10.1007/s00330-020-06929.
    PubMed         Abstract available


    Int J Urol

  8. HATAKEYAMA S, Narita S, Takahashi M, Sakurai T, et al
    Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
    Int J Urol. 2020 May 16. doi: 10.1111/iju.14258.
    PubMed         Abstract available


    J Natl Cancer Inst

  9. JEMAL A, Culp MB, Ma J, Islami F, et al
    Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.
    J Natl Cancer Inst. 2020 May 20. pii: 5837113. doi: 10.1093.
    PubMed         Abstract available


    PLoS One

  10. MACAGNO A, Athanasiou A, Wittig A, Huber R, et al
    Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer.
    PLoS One. 2020;15:e0233442.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  11. LU WC, Saha A, Yan W, Garrison K, et al
    Enzyme-mediated depletion of serum l-Met abrogates prostate cancer growth via multiple mechanisms without evidence of systemic toxicity.
    Proc Natl Acad Sci U S A. 2020 May 20. pii: 1917362117.
    PubMed         Abstract available


    Prostate

  12. SHI X, Sun J, Li H, Lin H, et al
    Antitumor efficacy of interferon-gamma-modified exosomal vaccine in prostate cancer.
    Prostate. 2020 May 19. doi: 10.1002/pros.23996.
    PubMed         Abstract available

  13. TABEI T, Taguri M, Sakai N, Koh H, et al
    Does screening for prostate cancer improve cancer-specific mortality in Asian men? Real-world data in Yokosuka City 15 years after introducing PSA-based population screening.
    Prostate. 2020 May 20. doi: 10.1002/pros.23997.
    PubMed         Abstract available

  14. HOU Y, Li H, Huo W
    THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway.
    Prostate. 2020 May 18. doi: 10.1002/pros.23989.
    PubMed         Abstract available


    Urology

  15. IINUMA K, Nakano M, Kato T, Kato D, et al
    Assessment of long-term changes in lower urinary tract symptoms in patients with prostate cancer who underwent low-dose-rate prostate brachytherapy.
    Urology. 2020 May 13. pii: S0090-4295(20)30540.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: